A comprehensive description of the contributions of Averill A. Liebow to the field of pulmonary pathology would be a monumental task. In preparation for writing this addendum to Dr. Lindskog's tribute to Dr. Liebow, the comments and reflections of former students and colleagues were sought to appreciate the flavor of the man, the personality, and the drive which led to so productive a career. A montage of the complete academician-pathologist, teacher, investigator-was assembled. This essay can outline only in part the directions of his research and his far-reaching insight, in Dr. Liebow's words, into the "labyrinths of the lungs." However, it is more likely that his greatest contributions can not be measured by any yardstick. Only in passing will we remind the reader that first and foremost Dr. Liebow was held in highest esteem as a dedicated instructor of the art and science of medicine and perhaps, on an even higher plane, as an educator with vision and wisdom.
fondness for his years in New Haven, but also his philosophy of preparation for a career in medicine.
William Thurlbeck, in the preface to a recent monograph on lung disease published by the International Academy of Pathology,2 dedicated the volume to the memory of Dr. Liebow and acknowledged him as one of the founding fathers of modern pulmonary pathology. Dr. Lindskog has recounted for us the stages of development of Dr. Liebow's career and the ultimate honors accorded him. But how did he come to shape the future and direction of pulmonary pathology? What new truths were made self-evident? And what legacies for the future were left to those choosing to investigate pulmonary diseases?
Dr. Liebow was himself a superb anatomist and was quick to impress upon students that, among the three basic pre-clinical disciplines, anatomy was the most fundamental. To pathology residents, he emphasized that knowledge of tissues under the microscope was paramount. Only by recognizing the normal could one appreciate the abnormal. It has been said that no one in his time surpassed Dr. Liebow in his ability to extract clues to the nature of disease from observations of tissue through the microscope or at the gross autopsy table. Pure anatomical studies are sprinkled liberally among his writings in medicine, often sparking innovative physiological studies or leading to important correlations in diseased states. The basis of many of his early observations was the plastic cast of the human or canine tracheobronchial tree and its vascular supply. This methodology, which was modified after the work of previous investigators and adapted for studies in his laboratory, provided a permanent specimen which could be measured, photographed, or even colorfully painted if the requirement was to delineate the bronchopulmonary segments. An important innovation was that the viscosity of the injection mass could be altered so that small air sacs and minute vessels could be filled, structures that would ordinarily be poorly seen or obliterated by dissection. Furthermore, by adding pigments to the plastic the various limbs of the pulmonary vascular tree could be selectively highlighted to reveal anastomoses, hypertrophy, or absence of vessels. This provided important information regarding the course of blood flow.
With time, hundreds of casts of both normal and abnormal lungs were studied and numerous reports emerged. Dr. Lindskog has previously referred to the monograph, Surgical Anatomy of the Bronchovascular Segments, authored with Doctors Hales and Bloomer [1] . Destructive inflammatory parenchymal lung disease was common in that day and preservation of functional or uninvolved lung tissue a common goal among surgeons. The elegant atlas of surgical anatomy of the lung facilitated the meticulous dissections necessary for conservation of pulmonary tissue. Too modestly, Dr. Lindskog skirts his own remarkable achievements. Enhanced definition of lung anatomy provided by lung casting enabled Dr. Lindskog to devise new procedures in those frontier days of thoracic surgery. The practicality of combined right lower and middle lobe resection through the bronchus intermedius was recognized, performed, and championed as a result of studying detailed casts of lung hilum anatomy [2] . The casts were also highly suitable for defining the anatomy of the collateral circulation to the lungs under experimental conditions, and more completely describing the normal bronchial circulation. The anatomy of the bron- [4] . Precapillary anastomoses between bronchial and pulmonary arterial circulations become functional and it is probable that new anastomotic channels are established between the two circulations distally within zones of inflammation. Salutary effects of this protective mechanism include the revascularization of lung with a diminishing capillary bed and the shunting of blood away from diseased parenchyma to a more favorable lung environment. An unfortunate experiment of nature, congenital pulmonary stenosis, produces a similar effect on the pulmonary collateral circulation. Casts prepared from patients with tetralogy of Fallot revealed an extensive mediastinal plexus of greatly enlarged bronchial arteries which extend into the lung to anastomose with the pulnonary arterial circulation. Ligation of the pulmonary artery of dogs provided the laboratory with a similar experimental model, upon which detailed physiological experiments and anatomic studies could be performed [5] .
Experiments concerned with the collateral circulation of the lung were to become the principal investigative thrust of Dr. Liebow's laboratory. This reflected his philosophy that it was insufficient to recognize alterations in structure alone. Instead, the interrelationship of structure and function must be relentlessly pursued. The canine model behaved as nature's human experiments had suggested. Significant collateral flow to lungs with ligated pulmonary arteries developed via the bronchial arterial circulation. Furthermore, following ligation of the pulmonary vein, the bronchial venous circulation responded in like fashion. Correlative physiological experiments showed that with time blood flow increases to the deprived lung, and this is accompanied by an increase in functional capacity, as measured by gas exchange. This suggested to Dr. Liebow that a greatly expanded bronchial arterial and collateral venous circulation might return sufficient oxygenated blood to systemic veins to be effective therapy for transposition of the great vessels. This model of an autogenous oxygenator was successfully created in the laboratory [6] .
The ideas of Vineberg and others suggested to Dr. Liebow that cardiac revascularization utilizing the expanded bronchial circulation might be feasible. Experiments in the dog established that the collateral circulation to the heart is enhanced following ligation of a pulmonary artery and creating adhesions between the lung and heart [7, 8] . These experiments, performed in the mid to late 1950s, raised fundamental questions which were asked then and which persist today. What made the blood vessels grow, and why was the growth orderly so that the circulations were not hopelessly intermixed? Preliminary experiments were begun in the laboratory to test the influence of hormones on blood vessel growth. These same issues are being addressed in today's most technically sophisticated laboratories.
Dr. Liebow's interest in and fascination with many aspects of the pulmonary circulation continued throughout his career. The physiology of hypervolemic and neurogenic pulnionary edema was studied in his laboratory. He described important aspects of vascular pathology in pulmonary emphysema, notably the expansion of the bronchial venous collateral circulation [9] . Experimental pulmonary arterial hypertension (aorta to pulmonary artery shunt) and effects of hyperkinesis (total pulmonary flow diverted to one lung) were shown to be reliable models for human pulmonary hypertension. These interests and acknowledged expertise culminated in several major reviews on pulmonary hypertension and a chapter in S.E. Gould's text, Pathology of the Heart, a treatise written with Dr. S.E. Downing, largely dealing with the pathology of the pulmonary vasculature [10, 11] .
With Students of pulmonary neoplasia recognize as classics two additional papers by Dr. Liebow. In 1960 a review of the subject of broncho-alveolar carcinoma was published in Advances in Internal Medicine [13] . This still-controversial lesion was there better defined, and much of the confusion surrounding previous nomenclature eliminated by this study. The discussion of the pathology, histogenesis, and natural history of this pulmonary carcinoma remains definitive today. In 1965, Dr. Edward Meyer and Dr. Liebow pointed out the distinct association between peripheral scarring of the lung, atypical epithelial proliferation, and the development of lung carcinoma [14] . The important analogy was drawn between the sequence of metaplasia, carcinoma in situ, and carcinoma in the large bronchi previously described by Auerbach, and peripheral lung injury as a substrate upon which carcinogens might act.
A word about Dr. Liebow's contributions to the field of exfoliative cytology is indicated. In his hospital practice in New Haven, Dr. Liebow devoted much time and energy to the cytology of body fluids and exfoliated tissue cells. He seemed fascinated by the challenge to define the events going on internally as reflected in the "flotsam and jetsam" of body secretions. Most days in the cytology laboratory began with Dr. Liebow holding court among pathology residents and cytotechnologists. Emphasis was placed on the accurate definition of all findings: benign, atypical, or malignant. Identification of non-cellular clues to the nature of the disease and identification of artifacts were additional objectives. While growing in this field, Dr. Liebow insisted upon close contact with the referring physicians for those clinical details which might shade an interpretation. Only on weekends, when the lab was quiet, was there time for self-education and study by correlating the cytological findings with the histology provided by tissue biopsy. Dr. Liebow transmitted to residents and fellows who learned cytology with him not only his enthusiasm and expertise, but his essentially cautious approach to the field. In one publication Dr. Liebow lamented the shortcomings of work of the previous decade which were self-fulfilling prophesies of diagnosing cancer cytologically in patients highly suspect of cancer-"a diagnosis of carcinoma based on examination of the sputum is likely to be correct even if the conclusion is wrongly drawn on the basis of finding metaplastic or other noncancerous epithelium." Thus the stage was set for the scrutiny in the New Haven Hospital of large numbers of control patients ". . . in whom the possibility of a carcinoma is remote." The objective was to delineate the normal and variations of normal before conclusions about the abnormal were reached. He went on to report percentages of correct and false positive diagnoses in that series. This remains one of the earliest and best studies in the literature describing the risk of correct interpretation versus error in cytological examination of bronchial secretions [15] .
Dr. Liebow in time became the foremost consultant in lung pathology in the United States. This had a salubrious effect upon our understanding of pulmonary reactions to injury. Unequaled as a morphologist and with incisive understanding of disease mechanisms, he could now begin to categorize and classify pulmonary disorders based on similarities of anatomical changes and clinical features. Lung biopsy techniques improved, more patients were studied histologically at a much earlier time in the clinical course of disease, and records of relatively uncommon conditions were accumulating at a more rapid rate in the files of consultants. Dr. Liebow's publications, based on his incomparable collection of referred material, are a compendium of the natural history of many pulmonary disorders. Indeed, several of his descriptive analyses represent the original definition of previously unrecognized conditions. Examples include pulmonary alveolar proteinosis, desquamative interstitial pneumonia, and bronchocentric granulomatosis [16, 17, 18] . Principles of his detailed analytical style which apply to all of Dr. Liebow's studies might be drawn from the proteinosis paper. Twenty-seven cases of a process in which ". . . the histologic structure of the lesions . . . is so characteristic and similar from one case to another" had accumulated in the files of the Armed Forces Institute of Pathology, the Massachusetts General Hospital, and the New Haven Hospital. They were reported in 1958 in collaboration with Drs. Rosen and Castleman as "Pulmonary alveolar proteinosis, a new entity." In addition to complete clinical and radiographic summaries of those patients and the profusion of excellent illustrative material to amplify the text of the anatomical changes, data from clinical investigative approaches such as histochemistry and biochemical and spectrographic analysis was included. The authors speculated concerning the pathogenesis of the disorder by comparing anatomic and radiographic "look-alikes," by considering the probable histogenesis of the lesions, and by attention to the exposure and occupational histories of patients. As knowledge of this still incompletely understood disorder has accumulated over the past two decades, largely through the development of successful laboratory models of the disease, we now realize how remarkably accurate those earlier speculations were. As Dr. Liebow suggested, alveolar proteinosis involves diffuse injury to alveolar pneumocytes, and many cases are triggered by exposure to toxic environmental agents.
Many other examples of definitive works emerged from the consultation practice of Averill Liebow-desquamative interstitial pneumonia (with Drs. Steer and Billingsley), bronchocentric granulomatosis and the relationship of that entity to allergic bronchopulmonary aspergillosis (with Drs. Katzenstein and Friedman), and bronchiolitis obliterans (with Drs. Gosink and Friedman) [19] , to name a few. In collaboration with Charles Carrington came important treatments of the subjects of eosinophilic pneumonias [20] , limited forms of Wegener's granulomatosis [21] , diffuse pulmonary lymphoreticular infiltrates (lymphocytic interstitial pneumonia) [22] , and atypical pulmonary lymphoreticular infiltrates (lymphomatoid granulomatosis) [23] . Each of these studies represents a scholarly exercise in descriptive morphological analysis and would stand alone as a classic in this regard. However, the papers are more far-reaching because suggestions for future study are virtually always proferred. Anatomical and clinical data are distilled to extract the pathogenetic mechanisms of disease; references to experimental pathology help in further defining the nature of the processes; pointing out features which suggest immunological, infectious, or toxic injury to lung provides guidance for investigative work to follow.
We always were cautioned by Dr. Liebow that the lung, although a complex organ, can only react to injury in a limited number of ways and that there was likely to be great difficulty ahead in sorting out the various agents and vectors of disease. Similar histological responses did not necessarily imply a common etiological insult. Thus bronchiolitis obliterans, which resulted in an obstructing lesion of small airways with polypoid granulation tissue proliferating within the lumen, might be the sequela of viral inflammation or inhalation of noxious fumes such as chlorine gas. We were taught that meticulous scrutiny of tissue for anatomical clues placed in overall context of tissue responses to injury was a useful clinical and investigative approach to the discipline of anatomic pathology.
We have briefly given an overview, by no means complete, of Averill Liebow's contribution to the field of lung pathology. His interest in pulmonary tumors continued unabated throughout his career. His papers on pseudotumors, peripheral carcinoid tumors, chemodectomas, benign clear-cell tumors, and lymphoangiomyomatosis of lung underscore that interest. In collaboration with investigators at the submarine base in Groton, Connecticut, he reported observations on pulmonary interstitial emphysema and air embolism incurred during decompression. Abnormal muscular proliferation in lung, structural changes in ageing lungs, the nature of the Kultschitzky cell-each received his consideration. Contributions to textbooks and monographs were considerable and have largely been covered in Dr. Lindskog's tribute and in the preceeding paragraphs. There were others.
Legacies in medicine are not necessarily left by discoveries, books, chapters, or an extended bibliography. Dr. Liebow's formal publications achieve all of that, and in total comprise a voluminous, unique, and distinct contribution to the field of lung pathology. So how do we measure this man's gift to us as compared to those of other great scientists, teachers, and physicians? I prefer to state simply that above all he was an exemplary scholar in two aspects of his career. First, truth was of the essence, he consistently admonished students and colleagues to seek the truth through investigation and discovery; truth was a by-product of self-education and application of the scientific method. Second, he left in his wake evidence that the seeds of his quest for truth were broadcast widely and fell on fertile soil, to be perpetuated. In a recent appreciation Dr. Colin Bloor emphasizes the number of former students of Dr. Liebow who now occupy positions in academic medicine, not only in pulmonary disease, but in many disciplines, adding, "he was quick to support the good man and good idea."3 On a personal note, I recall that on June 30, 1973, in La Jolla, on the stroke of midnight he spontaneously proposed a toast observing the appointment of a new assistant professor to the faculty of the Yale Department of Pathology. This, Dr. Liebow viewed as high honor and achievement. For that gesture, for subsequent support and encouragement, and for giving us the many building blocks, not the least of which is truth, to build careers in academic medicine, I, we thank Averill Liebow. 
